Shirin Pinto MD in Dardenne Prairie, Missouri

Home Missouri Dardenne Prairie

Shirin Pinto MD has Emergency Medicine as her primary medical specialty. Their primary office is: 7909 Hwy N in Dardenne Prairie, Missouri. They attended Sorry, her university is not listed and graduated in 1974 (around 50 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Shirin C Pinto MD Office Phone and Directions

Shirin Pinto MD
7909 Hwy N
Dardenne Prairie, Missouri 63368
636-625-1560

Patient Ratings
Please rate your experience with Shirin Pinto MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 636-625-1560

Enter a starting address:

Healthcare Info for Shirin Pinto MD

Medical School: Sorry, her university is not listed
Graduation Year: 1974
The Primary Medical Specialty for Shirin Pinto MD is listed as: Emergency Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 50
PAC (PECOS ID)#: 1850331554
NPI #: 1134102262
NPI Created On: 11/22/2005
NPI Last Updated Listed as: 07/29/2008
Primary Taxonomy Code: 207P00000X
License Number:
R6D97
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
Administration of influenza virus vaccine
Administration of pneumococcal vaccine

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835977535

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Virology & Specialty Care

Name of Drug #1: Xofluza

Open Associated Drug #1: 50242-828-02